Skip to main content

Advertisement

Log in

Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the utility of multiphase contrast-enhanced computed tomography (CT) findings alone and in combination for differentiating focal-type autoimmune pancreatitis (f-AIP) from pancreatic carcinoma (PC).

Methods

The study group comprised 22 f-AIP lesions and 61 PC lesions. Two radiologists independently evaluated CT findings. Frequencies of findings were compared between f-AIP and PC. Statistical, univariate and multivariate analyses were performed.

Results

Homogeneous enhancement during the portal phase (AIP, 59 % vs. PC, 3 %; P < 0.001), dotted enhancement during the pancreatic phase (50 % vs. 7 %; P < 0.001), duct-penetrating sign (46 % vs. 2 %; P < 0.001), enhanced duct sign (36 % vs. 2 %; P < 0.001) and capsule-like rim (46 % vs. 3 %; P < 0.001) were more frequently observed in AIP. Ring-like enhancement during the delayed phase (5 % vs. 46 %; P < 0.001) and peripancreatic strands with a length of at least 10 mm (5 % vs. 39 %; P = 0.001) were more frequently observed in PC. AIP was identified with 82 % sensitivity and 98 % specificity using four of these seven findings. Multivariate analysis revealed significant differences in dotted enhancement (P = 0.004), duct-penetrating sign (P < 0.001) and capsule-like rim (P = 0.007).

Conclusions

The combination of CT findings may allow improvements in differentiating f-AIP from PC.

Key Points

f-AIP can mimic PC on imaging findings.

The differentiation of f-AIP from PC is important in patient management.

Some CT findings can be used to identify AIP.

The combination of CT findings will improve differentiation from PC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AIP:

Autoimmune pancreatitis

CBD:

Common bile duct

CT:

Computed tomography

f-AIP:

Focal-type autoimmune pancreatitis

MPD:

Main pancreatic duct

MRI:

Magnetic resonance imaging

PC:

Pancreatic carcinoma

References

  1. Kamisawa T, Okamoto A (2006) Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 41:613–625

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Sahani DV, Kalva SP, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352

    Article  PubMed  Google Scholar 

  3. Kawamoto S, Siegelman SS, Hruban RH, Fishman EK (2008) Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics 28:157–170

    Article  PubMed  Google Scholar 

  4. Yang DH, Kim KW, Kim TK et al (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94–102

    Article  CAS  PubMed  Google Scholar 

  5. Weber SM, Cubukcu-Dimopulo O, Palesty JA et al (2003) Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 7:129–137

    Article  PubMed  Google Scholar 

  6. Abraham SC, Wilentz RE, Yeo CJ et al (2003) Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 27:110–120

    Article  PubMed  Google Scholar 

  7. Kamisawa T, Shimosegawa T, Okazaki K et al (2009) Standard steroid treatment for autoimmune pancreatitis. Gut 58:1504–1507

    Article  CAS  PubMed  Google Scholar 

  8. Shimosegawa T, Chari ST, Frulloni L et al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358

    Article  PubMed  Google Scholar 

  9. Okazaki K, Shimosegawa T, Itoh T et al (2012) Clinical diagnostic criteria for autoimmune pancreatitis 2011 (proposal). J Jpn Pancreas (Suizou) 27:17–25

    Article  Google Scholar 

  10. Ghazale A, Chari ST, Smyrk TC et al (2007) Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 102:1646–1653

    Article  CAS  PubMed  Google Scholar 

  11. Kamisawa T, Kim MH, Liao WC et al (2011) Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas 40:200–205

    Article  PubMed  Google Scholar 

  12. Levy MJ, Wiersema MJ, Chari ST (2006) Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 38(Suppl 1):S30–35

    Article  PubMed  Google Scholar 

  13. Bang SJ, Kim MH, Kim Do H et al (2008) Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas 36:84–89

    Article  PubMed  Google Scholar 

  14. Takahashi N, Fletcher JG, Fidler JL, Hough DM, Kawashima A, Chari ST (2008) Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol 190:280–286

    Article  PubMed  Google Scholar 

  15. Takahashi N, Fletcher JG, Hough DM et al (2009) Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol 193:479–484

    Article  PubMed  Google Scholar 

  16. Chang WI, Kim BJ, Lee JK et al (2009) The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis: comparison with chronic pancreatitis and pancreatic cancer. Pancreas 38:401–408

    Article  PubMed  Google Scholar 

  17. Sun GF, Zuo CJ, Shao CW, Wang JH, Zhang J (2013) Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol 19:3634–3641

    Article  PubMed Central  PubMed  Google Scholar 

  18. Irie H, Honda H, Baba S et al (1998) Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 170:1323–1327

    Article  CAS  PubMed  Google Scholar 

  19. Suzuki K, Itoh S, Nagasaka T, Ogawa H, Ota T, Naganawa S (2010) CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol 65:735–743

    Article  CAS  PubMed  Google Scholar 

  20. Kawai Y, Suzuki K, Itoh S, Takada A, Mori Y, Naganawa S (2012) Autoimmune pancreatitis: assessment of the enhanced duct sign on multiphase contrast-enhanced computed tomography. Eur J Radiol 81:3055–3060

    Article  PubMed  Google Scholar 

  21. Muhi A, Ichikawa T, Motosugi U et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836

    Article  PubMed  Google Scholar 

  22. Sugiyama Y, Fujinaga Y, Kadoya M et al (2012) Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer. Jpn J Radiol 30:296–309

    Article  CAS  PubMed  Google Scholar 

  23. Fujinaga Y, Kadoya M, Hamano H et al (2011) Radiologic findings of IgG4-related disease. Curr Immunol Rev 7:186–203

    Article  CAS  Google Scholar 

  24. Hattori Y, Gabata T, Zen Y, Mochizuki K, Kitagawa H, Matsui O (2010) Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings. Pancreas 39:1263–1270

    Article  PubMed  Google Scholar 

  25. Morana G, Cancian L, Pozzi Mucelli R, Cugini C (2010) Staging cancer of the pancreas. Cancer Imaging 10:S137–141

    Article  PubMed Central  PubMed  Google Scholar 

  26. Ichikawa T, Sou H, Araki T et al (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116

    Article  CAS  PubMed  Google Scholar 

  27. Zamboni G, Luttges J, Capelli P et al (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–563

    Article  PubMed  Google Scholar 

  28. Chari ST, Smyrk TC, Levy MJ et al (2006) Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4:1010–1016

    Article  PubMed  Google Scholar 

  29. Matsumoto S, Mori H, Kiyonaga M et al (2012) "Peripancreatic strands appearance" in pancreatic body and tail carcinoma: evaluation by multi-detector CT with pathological correlation. Abdom Imaging 37:602–608

    Article  PubMed  Google Scholar 

  30. Glaser J, Hogemann B, Krummenerl T et al (1987) Sonographic imaging of the pancreatic duct. New diagnostic possibilities using secretin stimulation. Dig Dis Sci 32:1075–1081

    Article  CAS  PubMed  Google Scholar 

  31. Takayama M, Hamano H, Ochi Y et al (2004) Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 99:932–937

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The scientific guarantor of this publication is Shinji Naganawa (Department of Radiology, Nagoya University Graduate School of Medicine). The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional review board approval was obtained. Written informed consent was waived by the institutional review board. Some study subjects or cohorts have been previously reported in 2012; Kawai Y, Suzuki K, Itoh S, et al. Autoimmune pancreatitis: assessment of the enhanced duct sign on multiphase contrast-enhanced computed tomography. Eur J Radiol 81:3055–3060. Specifically, ten focal-type autoimmune pancreatitis patients overlapped with the published study. In the previous study, only an enhancement of the main pancreatic duct wall of each patient was minutely evaluated, whereas in this study, other CT findings were additionally evaluated and regarding an enhancement of the main pancreatic duct wall, only whether present or absent was evaluated. Methodology: retrospective, diagnostic study, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naohiro Furuhashi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furuhashi, N., Suzuki, K., Sakurai, Y. et al. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol 25, 1366–1374 (2015). https://doi.org/10.1007/s00330-014-3512-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-014-3512-3

Keywords

Navigation